Compile Data Set for Download or QSAR
maximum 50k data
Found 21 Enz. Inhib. hit(s) with all data for entry = 9208
TargetTranscription intermediary factor 1-alpha(Homo sapiens (Human))
Dana-Farber Cancer Institute

US Patent
LigandPNGBDBM449269(US10702504, Compound I-A6)
Affinity DataIC50: <10nMAssay Description:The alpha assay was used to assess the binding of the compounds of the application to TRIM24 at various concentrations. All compounds were added at c...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetTranscription intermediary factor 1-alpha(Homo sapiens (Human))
Dana-Farber Cancer Institute

US Patent
LigandPNGBDBM449296(US10702504, Compound I-A12)
Affinity DataIC50: <10nMAssay Description:The alpha assay was used to assess the binding of the compounds of the application to TRIM24 at various concentrations. All compounds were added at c...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetTranscription intermediary factor 1-alpha(Homo sapiens (Human))
Dana-Farber Cancer Institute

US Patent
LigandPNGBDBM449285(US10702504, Compound I-A10)
Affinity DataIC50: <10nMAssay Description:The alpha assay was used to assess the binding of the compounds of the application to TRIM24 at various concentrations. All compounds were added at c...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetTranscription intermediary factor 1-alpha(Homo sapiens (Human))
Dana-Farber Cancer Institute

US Patent
LigandPNGBDBM449304(US10702504, Compound I-B2)
Affinity DataIC50: <10nMAssay Description:The alpha assay was used to assess the binding of the compounds of the application to TRIM24 at various concentrations. All compounds were added at c...More data for this Ligand-Target Pair
Ligand InfoKEGGPC cidPC sid
In DepthDetails US Patent
TargetTranscription intermediary factor 1-alpha(Homo sapiens (Human))
Dana-Farber Cancer Institute

US Patent
LigandPNGBDBM449294(US10702504, Compound I-A11)
Affinity DataIC50: <10nMAssay Description:The alpha assay was used to assess the binding of the compounds of the application to TRIM24 at various concentrations. All compounds were added at c...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetTranscription intermediary factor 1-alpha(Homo sapiens (Human))
Dana-Farber Cancer Institute

US Patent
LigandPNGBDBM50150812(CHEMBL3775853 | US10702504, Compound D)
Affinity DataIC50: <10nMAssay Description:The alpha assay was used to assess the binding of the compounds of the application to TRIM24 at various concentrations. All compounds were added at c...More data for this Ligand-Target Pair
In DepthDetails US Patent
TargetTranscription intermediary factor 1-alpha(Homo sapiens (Human))
Dana-Farber Cancer Institute

US Patent
LigandPNGBDBM50150808(CHEMBL3774507 | US10702504, Compound C)
Affinity DataIC50: <10nMAssay Description:The alpha assay was used to assess the binding of the compounds of the application to TRIM24 at various concentrations. All compounds were added at c...More data for this Ligand-Target Pair
TargetTranscription intermediary factor 1-alpha(Homo sapiens (Human))
Dana-Farber Cancer Institute

US Patent
LigandPNGBDBM449307(US10702504, Compound I-B4)
Affinity DataIC50: <10nMAssay Description:The alpha assay was used to assess the binding of the compounds of the application to TRIM24 at various concentrations. All compounds were added at c...More data for this Ligand-Target Pair
Ligand InfoKEGGPC cidPC sid
In DepthDetails US Patent
TargetTranscription intermediary factor 1-alpha(Homo sapiens (Human))
Dana-Farber Cancer Institute

US Patent
LigandPNGBDBM449224(US10702504, Compound I-A4)
Affinity DataIC50:  55nMAssay Description:The alpha assay was used to assess the binding of the compounds of the application to TRIM24 at various concentrations. All compounds were added at c...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetTranscription intermediary factor 1-alpha(Homo sapiens (Human))
Dana-Farber Cancer Institute

US Patent
LigandPNGBDBM449309(US10702504, Compound B)
Affinity DataIC50:  55nMAssay Description:The alpha assay was used to assess the binding of the compounds of the application to TRIM24 at various concentrations. All compounds were added at c...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetTranscription intermediary factor 1-alpha(Homo sapiens (Human))
Dana-Farber Cancer Institute

US Patent
LigandPNGBDBM449305(US10702504, Compound I-B3)
Affinity DataIC50:  55nMAssay Description:The alpha assay was used to assess the binding of the compounds of the application to TRIM24 at various concentrations. All compounds were added at c...More data for this Ligand-Target Pair
In DepthDetails US Patent
TargetTranscription intermediary factor 1-alpha(Homo sapiens (Human))
Dana-Farber Cancer Institute

US Patent
LigandPNGBDBM449303(US10702504, Compound I-B1)
Affinity DataIC50:  300nMAssay Description:The alpha assay was used to assess the binding of the compounds of the application to TRIM24 at various concentrations. All compounds were added at c...More data for this Ligand-Target Pair
Ligand InfoKEGGPC cidPC sid
In DepthDetails US Patent
TargetTranscription intermediary factor 1-alpha(Homo sapiens (Human))
Dana-Farber Cancer Institute

US Patent
LigandPNGBDBM449322(US10702504, Compound E)
Affinity DataIC50:  300nMAssay Description:The alpha assay was used to assess the binding of the compounds of the application to TRIM24 at various concentrations. All compounds were added at c...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetTranscription intermediary factor 1-alpha(Homo sapiens (Human))
Dana-Farber Cancer Institute

US Patent
LigandPNGBDBM449232(US10702504, Compound I-A5)
Affinity DataIC50:  300nMAssay Description:The alpha assay was used to assess the binding of the compounds of the application to TRIM24 at various concentrations. All compounds were added at c...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetTranscription intermediary factor 1-alpha(Homo sapiens (Human))
Dana-Farber Cancer Institute

US Patent
LigandPNGBDBM50148478(CHEMBL3769965 | US10702504, Compound A)
Affinity DataIC50:  750nMAssay Description:The alpha assay was used to assess the binding of the compounds of the application to TRIM24 at various concentrations. All compounds were added at c...More data for this Ligand-Target Pair
TargetTranscription intermediary factor 1-alpha(Homo sapiens (Human))
Dana-Farber Cancer Institute

US Patent
LigandPNGBDBM449284(US10702504, Compound I-A9)
Affinity DataIC50:  750nMAssay Description:The alpha assay was used to assess the binding of the compounds of the application to TRIM24 at various concentrations. All compounds were added at c...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetTranscription intermediary factor 1-alpha(Homo sapiens (Human))
Dana-Farber Cancer Institute

US Patent
LigandPNGBDBM449281(US10702504, Compound I-A8)
Affinity DataIC50:  750nMAssay Description:The alpha assay was used to assess the binding of the compounds of the application to TRIM24 at various concentrations. All compounds were added at c...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetTranscription intermediary factor 1-alpha(Homo sapiens (Human))
Dana-Farber Cancer Institute

US Patent
LigandPNGBDBM449280(US10702504, Compound I-A7)
Affinity DataIC50:  750nMAssay Description:The alpha assay was used to assess the binding of the compounds of the application to TRIM24 at various concentrations. All compounds were added at c...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetTranscription intermediary factor 1-alpha(Homo sapiens (Human))
Dana-Farber Cancer Institute

US Patent
LigandPNGBDBM449221(US10702504, Compound I-A3)
Affinity DataIC50:  750nMAssay Description:The alpha assay was used to assess the binding of the compounds of the application to TRIM24 at various concentrations. All compounds were added at c...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetTranscription intermediary factor 1-alpha(Homo sapiens (Human))
Dana-Farber Cancer Institute

US Patent
LigandPNGBDBM449215(US10702504, Compound I-A1)
Affinity DataIC50:  750nMAssay Description:The alpha assay was used to assess the binding of the compounds of the application to TRIM24 at various concentrations. All compounds were added at c...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetTranscription intermediary factor 1-alpha(Homo sapiens (Human))
Dana-Farber Cancer Institute

US Patent
LigandPNGBDBM449220(US10702504, Compound I-A2)
Affinity DataIC50:  750nMAssay Description:The alpha assay was used to assess the binding of the compounds of the application to TRIM24 at various concentrations. All compounds were added at c...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent